Vassiliki Karantza

Company: Merck & Co

Job title: Associate Vice President - Clinical Research Oncology

Seminars:

Expanding the Neoantigen Strategy Beyond Melanoma: Evolving Target Selection Across Tumor Types to Expand PCV Applicability 11:30 am

• Translating lessons from V940 to inform indication expansion and optimize antigen design across tumor types with differing immune responsiveness • Validating evolving antigen strategies in early-stage settings to accelerate clinical translation and enable faster access • Navigating regulatory considerations to determine when antigen selection strategy constitutes a new product vs an extension of platform…Read more

day: Conference Day One